NCT07834255Completed
The Effect of Robotic Rehabilitation in Stroke Patients
The Effect of Robot-Assisted Upper Extremity Rehabilitation on Motor Functions, Shoulder Pain, Cognitive Functions and Glenohumeral Subluxation in Patients With Early Subacute Stroke
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
The goal of this randomized controlled clinical trial is to investigate the efficacy and safety of adding robot-assisted upper extremity therapy to conventional rehabilitation in patients with early subacute stroke.The primary objective is to evaluate whether integrating an upper extremity exoskeleton robot (ArmeoPower) with standard conventional therapy yields superior improvements compared to conventional physiotherapy alone. The study investigates outcomes across multiple clinical domains, including upper extremity motor functions, muscle tone/spasticity, hemiplegic shoulder pain, cognitive functions, glenohumeral subluxation, and overall functional independence in daily living activities.A total of 36 eligible stroke participants are randomly allocated into two parallel groups in a 1:1 ratio:Control Group (Conventional Therapy): Participants receive 30 sessions of conventional neurorehabilitation (40 minutes per session, 5 days per week for 6 weeks).Intervention Group (Robotic Therapy): Participants receive a combined protocol consisting of 20 sessions of conventional physiotherapy and 10 sessions of robot-assisted training (20 minutes per session, 2-3 times per week), completing a total of 30 intervention sessions over a 6-week period.Detailed clinical, functional, and structural assessments are conducted for all participants at baseline (pre-intervention) and immediately following the completion of the 6-week treatment protocol (post-intervention) to analyze within-group and between-group changes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 4 Sept 2026
- Start date
- 2 Jan 2026
- Primary completion date
- 20 Mar 2026
- Lead sponsor
- Lokman Hekim University
- Diseases
- Stroke
- NCT number
- NCT07834255
What you commit to
- Study type: Interventional
- Participants enrolled: 36
- From 2 Jan 2026 to the primary completion date, 20 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having a prior diagnosis of Impingement syndrome, Frozen shoulder, Rotator cuff injury
- Having a prior diagnosis of Alzheimer's, Dementia, Parkinson's disease
Other illness
- More than 1 month having passed since the stroke
- Having experienced more than one stroke
- Failure to provide the necessary participation in evaluation and treatment within the scope of the study
- Suffering a second stroke during the study process
Other
- Discharge before completing the study process
- Lack of willingness to participate in the study
- Loss of voluntary participation in the study
Who the study is looking for
- Stroke history between 2-4 weeks
- No prior stroke
- Age between 35-70 years
- No prior diagnosis of orthopedic upper extremity disease or orthopedic upper extremity surgery
- No prior diagnosis of neurological disease
- Cognitive status suitable for rehabilitation
- At a supported sitting level for the treatment group
- Having shoulder pain as assessed by the Brief Pain Inventory before the study
Age in the registry: 35 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.